Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?

被引：11
|
作者：
Zuin, Marco [1 ,2 ]
Rigatelli, Gianluca [3 ]
Del Favero, Giuseppe [4 ]
Picariello, Claudio [1 ]
Meggiato, Tamara [4 ]
Conte, Luca [1 ]
Faggian, Giuseppe [5 ]
Zuliani, Giovanni [2 ]
Roncon, Loris [1 ]
机构：
[1] Rovigo Gen Hosp, Dept Cardiol, Rovigo, Italy
[2] Univ Ferrara, Sect Internal & Cardiopulm Med, Dept Med Sci, Ferrara, Italy
[3] Rovigo Gen Hosp, Dept Cardiovasc Diag & Endoluminal Intervent, Rovigo, Italy
[4] Rovigo Gen Hosp, Dept Gastroenterol, Rovigo, Italy
[5] Univ Verona, Dept Cardiac Surg, Verona, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2016年 / 223卷
关键词：
Coronary artery disease; Helicobacter pylori; Cardiovascular prevention; METAANALYSIS;
D O I：
10.1016/j.ijcard.2016.08.320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [31] Association between Helicobacter. pylori and coronary artery disease
    Davoudi, Setareh
    Omran, Abbas Salehi
    Boroumand, Mohammad Ali
    Rahimian, Nasrin
    Saadat, Soheil
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2011, 6 (01): : 107 - 112
  • [32] Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?
    Mohamed Riad
    The Egyptian Heart Journal, 73
  • [33] Meta analysis of the correlation between Helicobacter pylori infection and coronary heart disease
    Chen, Qiansheng
    Huang, Meihua
    Chen, Kaihong
    Fang, Yong
    Li, Weiguo
    Li, Ganyang
    Chen, Liling
    Jiang, Tianrong
    Lan, Shiqian
    Lin, Dong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1396 - 1402
  • [34] Is there an association between Helicobacter pylori infection and coronary heart disease?
    Pellicano, R
    Mladenova, I
    Broutet, N
    Salmi, LR
    Mégraud, F
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (07) : 611 - 619
  • [35] Is there an association between Helicobacter pylori infection and coronary heart disease?
    Rinaldo Pellicano
    Irena Mladenova
    Nathalie Broutet
    Louis-Rachid Salmi
    Francis Mégraud
    European Journal of Epidemiology, 1999, 15 : 611 - 619
  • [36] Furazolidone-Based Quadruple Therapy for Eradication of Helicobacter pylori Infection in Peptic Ulcer Disease
    Jahromi, Rahim Raoufi
    Mirzaei, Jamal
    Rajabi, Jalil
    Shokouh, Seyed Javad Hoseini
    Liaghat, Taraneh
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2014, 9 (03):
  • [37] Efficacy of Helicobacter pylori eradication therapy in chronic liver disease
    Jung, S. W.
    Lee, S. W.
    Hyun, J. J.
    Kim, D. I.
    Koo, J. S.
    Yim, H. J.
    Park, J. J.
    Lee, H. S.
    Chun, H. J.
    Um, S. H.
    Choi, J. H.
    Kim, C. D.
    Ryu, H. S.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (02) : 134 - 140
  • [38] Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
    Kobayashi, Satoshi
    Joshita, Satoru
    Yamamoto, Chikara
    Yanagisawa, Takumi
    Miyazawa, Takayuki
    Miyazawa, Megumi
    Kubota, Daisuke
    Sato, Junichi
    Umemura, Takeji
    Tanaka, Eiji
    MEDICINE, 2019, 98 (30) : e16619
  • [39] Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article
    Mi, Changmin
    Suo, Baojun
    Tian, Xueli
    Wang, Yuxin
    Ma, Lingling
    Song, Zhiqiang
    HELICOBACTER, 2024, 29 (02)
  • [40] Helicobacter pylori Infection is a Significant Factor Risk for Hyperhomocysteinemia in the Patients with Coronary Artery Disease
    Fallah, Soudabeh
    Moradi, Nariman
    Reza, Fadaei
    Reza, Ahmadi
    Azardokht, Tabatabei
    Seifi, Morteza
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2016, 59
12345